PRC1 and hepatocellular carcinoma: Remarkably, Tang et al. (2019) demonstrated that the upregulation of miR-194 in HCC diminishes the expression of PRC1 and β-catenin accompanied by increased E-cadherin expression leading to EMT inhibition and Wnt/β-catenin signaling pathway inactivation.